Keppel shares tumble as Temasek scraps $3 billion bid after conglomerate’s loss

SINGAPORE Shares in Singapore’s Keppel Corp fell 13% on Tuesday after Temasek Holdings abandoned its $3 billion offer for the conglomerate by invoking a material adverse change clause following the company’s poor financial results.

Keppel’s large second-quarter loss that breached a threshold in the state investor’s offer to buy majority control had boosted the risk Temasek would abandon the deal.

“It was a surprise, as my base case was that Temasek would have proceeded, but with a lower offer price,” said KGI Securities analyst Joel Ng.

Shares of Keppel, whose businesses range from property development to rig-building, fell 10.7% after dropping as much as 13% to their lowest in more than four years. The shares, which did not trade on Monday due to a public holiday, were the worst performing on the main stock index.

The stock is down 19% since it flagged a hit to second-quarter profits on July 24.

Expectations had grown that Temasek would lead much-needed consolidation in the rig-building sector after taking majority control of Keppel. The industry has been battered by a long period of low oil prices exacerbated by the coronavirus crisis.

Anticipation of a deal strengthened in June, when Temasek backed a S$2.1 billion rights issue by Sembcorp Marine, Keppel’s smaller competitor.

“The withdrawal will put a spanner in the works – it was widely expected that there would be some alliance between Keppel’s marine business and Sembcorp Marine, with Temasek being the largest mutual shareholder,” said Justin Tang, head of Asian research at United First Partners.

Separately, shareholders of Sembcorp Marine and its parent approved the rights issue. Sembcorp Marine shares rose 1.4%.

Last October, Temasek offered to raise to 51% its stake of a fifth of Keppel.

“We continue to believe in the inherent value of Keppel’s business, and have a strong balance sheet and support from our network of banks to finance the group’s operations and growth initiatives,” Keppel said in a statement late on Monday.

Also Watch

Sushant Death Probe: What’s The Mystery Behind The Rs.15 Crores Missing From Sushant’s Account?

(Additional reporting by Aradhana Aravindan; Editing by Clarence Fernandez and Louise Heavens)

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor


Array
(
[videos] => Array
(
[0] => Array
(
[id] => 5f32a0dc046bae25c91d4ecc
[youtube_id] => -2VrM-V3iQ4
Keppel shares tumble as Temasek scraps $3 billion bid after conglomerate’s loss => Sushant Death Probe: What’s The Mystery Behind The Rs.15 Crores Missing From Sushant’s Account?
)

[1] => Array
(
[id] => 5f329e85046bae25c91d4e8c
[youtube_id] => Vr0gVMyglAs
Keppel shares tumble as Temasek scraps $3 billion bid after conglomerate’s loss => Sachin Pilot: Personal Attacks In Potitics Are Unfortunate & Regrettable | CNN News18
)

)

[query] => https://pubstack.nw18.com/pubsync/v1/api/videos/recommended?source=n18english&channels=5d95e6c378c2f2492e2148a2,5d95e6c278c2f2492e214884,5d96f74de3f5f312274ca307&categories=5d95e6d7340a9e4981b2e10a&publish_min=2020-08-08T13:48:02.000Z&publish_max=2020-08-11T13:48:02.000Z&sort_by=date-relevance&order_by=0&limit=2
)

Speak Your Mind

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get in Touch

350FansLike
100FollowersFollow
281FollowersFollow
150FollowersFollow

Recommend for You

Oh hi there 👋
It’s nice to meet you.

Subscribe and receive our weekly newsletter packed with awesome articles that really matters to you!

We don’t spam! Read our privacy policy for more info.

You might also like

Cricket’s Dark Underbelly Once Again Exposed After Corruption Bans

Umar Akmal has been banned for three years. (Photo...

Here Are 29 ‘Get Out And Go’ Stocks For...

These stocks will benefit when consumers are no longer...

Scientists Funded By Chan Zuckerberg Initiative Accuse Facebook Of...

TOPLINE More than 140 scientists funded by the Chan Zuckerberg initiative (CZI) publicly called...

FDA Warns Against Using Drugs Promoted By Trump After...

TOPLINE The U.S. Food and Drug Administration on Friday warned Americans against taking...